Sources of Antibiotics

Long before the emergence of modern medicine, ancient civilizations relied on naturally occurring substances to prevent and manage infections. Traditional healing systems incorporated medicinal plants, plant extracts, moulds, and other natural materials believed to possess therapeutic properties. Although these practices were primarily developed through observation, experience, and accumulated indigenous knowledge rather than modern scientific methods, they provided an early foundation for the search for substances capable of combating infectious diseases.

Natural sources have continued to play an important role in the development of antimicrobial therapy. Before the widespread availability of conventional healthcare and synthetic pharmaceuticals, communities used medicinal plants, natural extracts, and other traditional preparations to treat infections, support wound healing, and manage various illnesses. This knowledge was transmitted across generations and remains relevant in many communities, particularly in rural and resource-limited settings where access to pharmaceutical medicines may be restricted.

Plants are particularly valuable sources of biologically active compounds with potential antimicrobial properties. Different plant parts, including leaves, roots, bark, seeds, flowers, and rhizomes, contain diverse phytochemicals such as alkaloids, flavonoids, tannins, terpenoids, and phenolic compounds. These substances may affect microorganisms through several mechanisms, including disruption of cell membranes, inhibition of essential enzymes, interference with nucleic acid synthesis, and impairment of other cellular processes. Their biological activity has therefore attracted considerable scientific interest as researchers continue to investigate natural products as potential sources of antimicrobial agents.

Several medicinal plants have a long history of traditional use. Examples include neem (Azadirachta indica), garlic (Allium sativum), ginger (Zingiber officinale), tea tree (Melaleuca alternifolia), and moringa (Moringa oleifera). Garlic contains allicin, a sulfur-containing compound that has demonstrated antimicrobial activity against several microorganisms under laboratory conditions. Ginger contains gingerols and related bioactive compounds, while neem and moringa contain a range of phytochemicals that have been investigated for their biological activities. Tea tree oil, obtained from the leaves of Melaleuca alternifolia, has also been studied for activity against selected bacteria and fungi. However, laboratory activity does not necessarily demonstrate clinical effectiveness, and further investigation is required to establish appropriate doses, safety, pharmacological properties, and therapeutic applications.

Microorganisms themselves constitute another major source of antimicrobial compounds. Certain bacteria, particularly species belonging to the genus Streptomyces, produce substances that inhibit competing microorganisms in their natural environments. Members of the genus Bacillus are also known to produce biologically active antimicrobial compounds. Fungi have contributed substantially to antibiotic discovery as well. Penicillin, originally obtained from Penicillium moulds, and cephalosporins, initially derived from Acremonium species, are important examples of antibiotics originating from microbial natural products. Many of these compounds were subsequently chemically modified to improve their stability, safety, pharmacokinetic properties, and antimicrobial spectrum.

The discovery of penicillin by Alexander Fleming in 1928 represented a major milestone in antimicrobial medicine. Its subsequent development for clinical use helped establish the modern antibiotic era and stimulated systematic searches for additional antimicrobial substances. Researchers investigated bacteria, fungi, and other biological sources, leading to the discovery of numerous antibiotics that substantially improved the treatment of bacterial infections and transformed clinical practice.

As antibiotic research advanced, synthetic and semisynthetic approaches became increasingly important. Synthetic antibiotics are produced through chemical processes, whereas semisynthetic antibiotics are derived from naturally occurring compounds that are subsequently modified. These approaches enable scientists to alter molecular structures to enhance antimicrobial activity, improve absorption and distribution, increase stability, reduce toxicity, and address limitations associated with naturally occurring compounds. Antibiotic development expanded beyond the direct isolation of natural products to include rational chemical modification and the creation of entirely synthetic agents.

Modern biotechnology has further broadened the possibilities for antimicrobial discovery. Advances in microbiology, molecular biology, genomics, chemistry, and pharmaceutical science have enabled researchers to identify novel antimicrobial compounds, investigate their mechanisms of action, and optimize promising molecules. These technologies have also improved the ability to modify existing agents and explore biological resources that were previously difficult to study.

The search for new antibiotics has become increasingly urgent because of the emergence and spread of antimicrobial resistance. Excessive or inappropriate antibiotic use creates selective pressure that favours resistant microorganisms, reducing the effectiveness of existing treatments. This challenge has renewed interest in natural products, microbial metabolites, synthetic chemistry, biotechnology, and alternative strategies for antimicrobial discovery.

The development of antibiotics reflects centuries of evolving knowledge, progressing from traditional medicinal practices and natural antimicrobial substances to microbial discoveries, chemical innovation, and modern biotechnology. This history demonstrates the continuing importance of diverse biological and chemical resources in the search for effective therapies against infectious diseases.

Sources and production of antibiotics

Antibiotics are biologically active compounds capable of inhibiting or eliminating microorganisms and have played a fundamental role in the treatment of bacterial infections. Their origins are diverse, ranging from naturally produced compounds obtained from microorganisms to molecules generated through chemical synthesis and semi-synthetic modification. The discovery and development of antibiotics have therefore relied on both microbial biodiversity and advances in chemistry and biotechnology.

Microorganisms represent the most important natural source of antibiotics. Soil-dwelling microorganisms, particularly Streptomyces species and other actinomycetes, have historically yielded a large proportion of clinically important antibiotics. Fungi, especially species belonging to the genera Penicillium and Acremonium, have also provided major antibiotic classes, including penicillins and cephalosporins. In nature, these microorganisms produce antimicrobial secondary metabolites as part of their ecological interactions, including competition with neighboring microorganisms. Fermentation processes can be used to cultivate antibiotic-producing organisms and recover these compounds on an industrial scale.

Synthetic antibiotics are produced entirely through chemical processes rather than being directly obtained from living organisms. Advances in medicinal chemistry have enabled researchers to design molecules with specific antibacterial properties, optimize their pharmacological characteristics, and overcome limitations associated with naturally occurring compounds. Fully synthetic agents include several important classes of antibacterial drugs and have expanded the range of available therapeutic options.

Semi-synthetic antibiotics occupy an intermediate position between these two approaches. They are derived from naturally produced antibiotic molecules that are subsequently modified through chemical or enzymatic reactions. Such modifications can improve properties including antibacterial activity, stability, absorption, tissue penetration, or resistance to bacterial enzymes. Many widely used antibiotics are semi-synthetic derivatives, demonstrating the importance of combining microbial discovery with chemical innovation.

Microorganisms: Biological origin of antimicrobial compounds

Microorganisms constitute one of the most important natural reservoirs of antibiotics and other biologically active antimicrobial compounds. Their ability to produce substances that inhibit or destroy competing microorganisms has provided the foundation for the discovery and development of numerous therapeutic agents used in modern medicine. Although many antibiotics currently prescribed in clinical practice are not obtained directly and entirely from their original microbial producers, their molecular structures frequently originate from natural compounds synthesized by microorganisms. These naturally occurring molecules therefore serve as essential parent structures for the development of improved antimicrobial agents.

The production of antimicrobial substances is particularly prominent among certain groups of bacteria and fungi. Microorganisms synthesize these compounds as part of complex ecological interactions, allowing them to compete for nutrients, occupy ecological niches, and survive in environments containing diverse microbial populations. The extraordinary chemical diversity generated through microbial metabolism has consequently become a valuable resource for pharmaceutical research.

Members of the genus Bacillus are recognized producers of several antimicrobial substances. Bacitracin, a peptide antibiotic, is associated primarily with Bacillus subtilis and related species, whereas polymyxins, including polymyxin B and colistin, are produced by Paenibacillus species historically classified within the genus Bacillus. These compounds demonstrate the ability of bacterial organisms to produce structurally diverse molecules with potent activity against other microorganisms.

The genus Streptomyces has made an especially significant contribution to antibiotic discovery. Species belonging to this group of filamentous, soil-dwelling bacteria produce a wide range of secondary metabolites with antimicrobial properties. Streptomycin, one of the earliest important aminoglycoside antibiotics, was obtained from Streptomyces griseus. Several tetracycline-class antibiotics are also derived from compounds originally discovered from Streptomyces species. The remarkable biosynthetic capacity of these organisms has made them central to natural-product research and antimicrobial drug discovery.

Other microorganisms have contributed important antibiotics as well. Gentamicin, an aminoglycoside antibiotic, was originally isolated from Micromonospora purpurea. This organism belongs to a group of filamentous bacteria that are particularly productive sources of bioactive secondary metabolites. The discovery of gentamicin illustrates how organisms outside the traditionally emphasized Streptomyces group can provide clinically valuable antimicrobial compounds.

Fungi have also played a fundamental role in antibiotic development. Penicillins originated from species of Penicillium, with Penicillium chrysogenum becoming particularly important for industrial production. Cephalosporinsoriginated from compounds produced by the fungus historically identified as Cephalosporium acremonium, now classified as Acremonium chrysogenum. These discoveries demonstrated that fungal microorganisms could provide antimicrobial molecules with distinctive chemical structures and therapeutic properties.

Modern antibiotic development often extends beyond the direct use of microbial products. Natural compounds can be chemically modified to produce semisynthetic antibiotics with greater stability, improved absorption, broader antimicrobial activity, or reduced susceptibility to bacterial resistance mechanisms. Microorganisms should not be viewed merely as manufacturers of finished antibiotics; they are biological sources of molecular scaffolds that can be optimized through pharmaceutical chemistry and biotechnology.

The continuing exploration of microorganisms from soil, water, plants, marine environments, and other ecological niches therefore remains important for identifying new antimicrobial structures. Advances in genomics, genome mining, fermentation technology, and synthetic biology have further expanded the ability to investigate microbial biosynthetic pathways. Microorganisms thus remain an indispensable biological foundation for antibiotic discovery, providing both established medicines and a continuing reservoir of chemical diversity for future antimicrobial development.

Synthesis: Laboratory production of antibiotics through chemical design

Synthetic antibiotics are antimicrobial agents produced through chemical synthesis rather than being obtained directly from their natural biological sources. The process involves designing and constructing a desired antibiotic molecule in the laboratory by using controlled chemical reactions. Instead of depending on microorganisms, plants, or other natural materials to supply the final drug, scientists reproduce the required molecular structure from selected chemical starting materials. This approach allows the properties of an antimicrobial compound to be deliberately controlled and, where necessary, modified to improve its therapeutic performance.

The development of synthetic antibiotics generally begins with the identification of a molecular structure capable of interfering with an essential process in microorganisms. Researchers study the chemical arrangement responsible for antimicrobial activity and then determine how that structure can be produced artificially. Different chemical reactions may be used to assemble the molecule step by step, including reactions that introduce, remove, or modify specific functional groups. Through this process, scientists can obtain compounds with defined chemical compositions and predictable characteristics.

A major advantage of chemical synthesis is that it can reduce dependence on the original natural source of an antimicrobial compound. Natural products may occur in very small quantities, may require extensive purification, or may be difficult and expensive to obtain consistently. Laboratory synthesis can provide an alternative means of producing the required compound on a larger scale. It may also permit researchers to alter the structure of an existing antimicrobial molecule and create derivatives with improved activity, stability, absorption, or resistance to enzymatic degradation.

Synthetic production has also contributed significantly to the expansion of antimicrobial drug development. Once an important chemical structure has been identified, chemists can systematically investigate related compounds by changing particular parts of the molecule. These structural modifications may produce substances with different antimicrobial spectra or pharmacological properties. Such chemical optimization is particularly important when microorganisms develop resistance to established antibiotics, because modified molecules may retain activity against organisms that are less susceptible to older drugs.

One historically important example associated with synthetic production is chloramphenicol. Chloramphenicol was originally obtained from Streptomyces venezuelae and was subsequently produced through chemical synthesis. Its structure contains several functional groups that can be assembled through laboratory chemical reactions, making it an important example of how an antibiotic originally discovered from a natural source can later be manufactured synthetically. Chloramphenicol acts primarily by inhibiting bacterial protein synthesis through interaction with the bacterial ribosome.

It is important to distinguish synthetic antibiotics from antibiotics that are merely purified from natural organisms. In a naturally derived antibiotic, the producing microorganism or biological source supplies the compound, which is then isolated and purified. In synthetic production, the desired molecule is constructed through chemical processes under controlled laboratory or industrial conditions. There is also an intermediate category known as semi-synthetic antibiotics, in which a naturally produced antibiotic molecule is chemically modified to obtain a new derivative.

Synthesis represents an important strategy in antibiotic development and manufacturing. It combines microbiology, medicinal chemistry, and pharmaceutical technology to produce antimicrobial compounds with carefully defined structures. By allowing scientists to construct and modify antibiotic molecules rather than relying exclusively on natural sources, chemical synthesis provides an important foundation for developing and improving antimicrobial therapies.

Semi-synthesis: Chemical modification of natural products for improved therapeutic performance

Semi-synthesis is an important strategy in pharmaceutical science in which a naturally occurring compound is chemically modified to produce a new drug with improved therapeutic properties. Unlike fully synthetic drugs, which are constructed entirely from simple chemical building blocks, semi-synthetic drugs begin with a biologically produced substance obtained from a natural source. This starting material may be produced by microorganisms, plants, or other biological systems and is subsequently altered through carefully controlled chemical reactions.

The process commonly begins with the production or isolation of a natural compound. Microorganisms such as bacteria and fungi are particularly valuable because they can produce complex molecules through fermentation. In industrial pharmaceutical production, the selected microorganism is cultivated under controlled conditions that provide suitable nutrients, temperature, pH, aeration, and other factors required for efficient biosynthesis. Once sufficient quantities of the desired compound have accumulated, the product is recovered and purified from the fermentation mixture.

The purified natural compound then serves as the chemical starting material for semi-synthesis. Chemists introduce specific structural changes to the molecule, such as adding, removing, replacing, or modifying functional groups. These alterations can change important characteristics of the drug, including its potency, stability, solubility, absorption, distribution, resistance to enzymatic degradation, and duration of action. The objective is not simply to create a different molecule, but to preserve the useful biological activity of the natural compound while overcoming one or more of its limitations.

A classic example is the development of semi-synthetic penicillins. Penicillin itself is naturally produced by species of Penicillium. Although natural penicillin has significant antibacterial activity, its usefulness can be limited by factors such as susceptibility to bacterial β-lactamases and its spectrum of activity. Scientists therefore developed modified penicillin derivatives by altering the side chain attached to the penicillin nucleus. Examples include ampicillin, amoxicillin, oxacillin, cloxacillin, and dicloxacillin. These modifications produced drugs with different antibacterial spectra, pharmacokinetic properties, and resistance to certain bacterial enzymes.

Cephalosporins provide another important group of semi-synthetic antibiotics. Their basic structural nucleus was originally obtained from naturally occurring cephalosporin compounds produced by microorganisms. Chemical modification of this nucleus generated numerous generations of cephalosporins with progressively different antibacterial properties. Examples include cephalexin, cefuroxime, cefotaxime, ceftriaxone, and cefepime. Structural changes in their side chains have helped influence their antibacterial spectrum, stability, pharmacokinetic behavior, and resistance to some β-lactamases.

Semi-synthesis is not restricted to antibiotics. An important example from antimalarial therapy is artemether, which is derived from artemisinin, a natural compound obtained from Artemisia annua. Artemether is produced by chemically modifying artemisinin to obtain a derivative with useful pharmaceutical characteristics. Other artemisinin derivatives include artesunate and dihydroartemisinin. These compounds demonstrate how natural products can provide valuable molecular frameworks that are subsequently optimized through chemical modification.

Other examples of semi-synthetic drugs include hydrocodone, derived from morphine or codeine-related natural alkaloids, and buprenorphine, developed from thebaine. In each case, chemical modification changes selected properties of the original natural molecule while retaining a therapeutically useful biological framework. Semi-synthesis creates a bridge between natural-product biosynthesis and modern medicinal chemistry. It allows scientists to exploit the structural complexity produced by living organisms while using chemical techniques to improve therapeutic performance. This approach has contributed substantially to the development of antibacterial, antimalarial, analgesic, and other important medicines.

References

Russell, A. D. (2004). Types of antibiotics and synthetic antimicrobial agents. In S. P. Denyer, N. A. Hodges, & S. P. Gorman (Eds.), Hugo and Russell’s pharmaceutical microbiology. Blackwell Publishing.

Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023). Origin of antibiotics and antibiotic resistance, and their impacts on drug development: A narrative review. Pharmaceuticals, 16(11), 1615.

Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., Moreira, M. B., Li, Y., Luzhetskyy, A., Medema, M. H., Pernodet, J.-L., Stadler, M., Tormo, J. R., Zhang, Y., & Müller, R. (2021). Towards the sustainable discovery and development of new antibiotics. Nature Reviews Chemistry, 5, 726–749.

Clardy, J., Fischbach, M. A., & Currie, C. R. (2009). The natural history of antibiotics. Current Biology, 19(11), R437–R441.

Kayser, O., & Averesch, N. J. H. (2025). Antibiotics. In Technical biochemistry. Springer.

Pancu, D. F., Scurtu, A., Macasoi, I. G., Marti, D., Mioc, M., Soica, C., Coricovac, D., Horhat, D., Poenaru, M., & Dehelean, C. (2021). Antibiotics: Conventional therapy and natural compounds with antibacterial activity—A pharmaco-toxicological screening. Antibiotics, 10(4), 401.

Bérdy, J. (2012). Thoughts and facts about antibiotics: Where we are now and where we are heading. The Journal of Antibiotics, 65, 385–395.

Ribeiro da Cunha, B., Fonseca, L. P., & Calado, C. R. C. (2019). Antibiotic discovery: Where have we come from, where do we go? Antibiotics, 8(2), 45.